The founder who reversed his own ten-year cascade
One drug at 29. Nine by 40. Then two independent systems: an Ayurvedic srotas assessment and modern diagnostics that pointed at the same upstream liver block. Remove the block, and the body does the rest. The numbers didn't just improve. They held and deepened as the medicines came off, from nine down to one.
Every symptom met a new prescription
Gout at 29. Diabetes at 33. Then cholesterol, back pain, a fatty liver and a gut that wouldn't settle. Each was medicated on its own. None asked why the alarms kept ringing.
The tests said “reassuring.” The scarring said otherwise.
Standard liver tests can look normal while the liver quietly scars. That is exactly what happened for years under routine monitoring.
2020 — ROUTINE LIVER PANEL
- Liver enzymes: in range
- Bilirubin, protein: normal
- Verdict at the time: "all clear"
Episodic, single-marker testing gave false comfort.
2025 — DEEPER FIBROSIS PANEL
A fibrosis score in the advanced-scarring band. The liver had been scarring silently for years while the ordinary tests smiled. A man better-monitored than most still progressed — undetected.
Two systems, blind to each other, pointed at the liver
This is the idea UN:BLOC is built on: read the body through two independent lenses. Where they agree is where you act.
A srotas assessment independently located a liver-channel obstruction as the root of the cascade with no lab values in view.
A fibrosis score and genetic testing independently reached the same organ — with no access to the srotas assessment. And the detail that mattered most: the liver enzymes had looked normal for years. The block sat upstream of anything a standard panel would catch.
Measured, not claimed
From the December 2025 baseline, the markers moved together because they shared one upstream cause. Then the medicines started coming off.
The reversal held on a fraction of the medication
This is the test that matters. The July 2026 panel was drawn on just one medicine and three supplements — down from nine. Nothing heavy was holding the line, yet the numbers didn't slip back. Several improved further.
The goal is full remission of the chronic-disease cascade within nine months, as the root block resolves. The reversal so far reached on one medicine and three supplements, down from nine, and continues on that path.
The changes no lab captures — and the ones that matter most
Biomarkers tell the clinical story. But day to day, these are what changed — and for the person living it, these matter most of all.
Energy that lasts
The mid-day crash is gone. Steady through the afternoon and productive into the late evening.
Deep, restoring sleep
Falling asleep easily and waking genuinely rested.
IBS in remission
The loose motions and bloating that struck most weeks have simply stopped.
The fog lifted
Clear-headed again — the mental fog that clouded focus has cleared.
The honesty that makes the wins believable
A case that only shows wins isn't a case study — it's a brochure. Here is what hasn't resolved, named plainly, each on its own track.
Methylation
Homocysteine is high and rising. This is a genetic (MTHFR) methylation issue — a different lever from the liver work. The signal points clearly to switching to active methyl-folate.
Vitamin D
Dipped into insufficiency. A simple repletion, already being corrected — not a failure of the method.
Metabolic vigilance
Insulin resistance ticked up slightly off-medication (still far below the starting point). The reversal is real; sustaining it is a lifelong practice, not a finish line.
“Disease is obstruction. Remove the block, and the body does the rest.”